Blog
RSS FeedPosted by Michael Wonder on 23 Jan 2020
Sick of high drug prices, insurers join hospitals to make their own generic medications
23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...
Posted by Michael Wonder on 23 Jan 2020
Update of the frequently asked questions for the PBS Botulinum Toxin Program
23 January 2020 - A revised version of the frequently asked questions for the PBS Botulinum Toxin Program is now available. ...
Posted by Michael Wonder on 23 Jan 2020
Jazz Pharmaceuticals submits new drug application for JZP-258 for cataplexy and excessive daytime sleepiness associated with narcolepsy
22 January 2020 - Jazz Pharmaceuticals today announced the submission of a new drug application to the U.S. Food and Drug ...
Posted by Michael Wonder on 22 Jan 2020
Reimbursement for Repatha to expand treatment options for ASCVD patients
22 January 2020 - Amgen is set to expand treatment options for atherosclerotic cardiovascular disease patients with Repatha, a high-cholesterol treatment, ...
Posted by Michael Wonder on 22 Jan 2020
Roche wins approval for cancer drug Kadcyla in fast-growing China market
23 January 2020 - Roche said on Wednesday China had approved the import of its Kadcyla drug for breast cancer, another ...
Posted by Michael Wonder on 22 Jan 2020
Morneau says Ottawa will need to work with provinces on issues like universal pharmacare
19 January 2020 - Finance Minister Bill Morneau said that the federal government will often need to work together with provinces ...
Posted by Michael Wonder on 22 Jan 2020
Supernus announces FDA acceptance for review of new drug application for SPN-812 for the treatment of ADHD
21 January 2020 - PN-812 (viloxazine hydrochloride), a once-daily novel serotonin norepinephrine modulating agent, demonstrates a reduction in ADHD-RS-5 total score ...
Posted by Michael Wonder on 22 Jan 2020
Court of Justice upholds EMA’s approach to transparency
22 January 2020 - EMA welcomes today’s two appellate judgments by the Court of Justice that confirmed, in clear and ...
Posted by Michael Wonder on 22 Jan 2020
The FDA continues to struggle with the implications of approving Sarepta’s drugs
22 January 2020 - New documents released Wednesday lay bare the stark divide within the Food and Drug Administration regarding ...
Posted by Michael Wonder on 22 Jan 2020
Competition, not capping increases, is the cure for high drug prices
22 January 2020 - Soaring prescription drug prices are putting financial pressure on families across the country. ...
Posted by Michael Wonder on 22 Jan 2020
Supreme Court refuses to fast-track a challenge to the Affordable Care Act
22 January 2020 - The Supreme Court on Tuesday denied a motion to fast-track a challenge to the Affordable Care ...
Posted by Michael Wonder on 22 Jan 2020
Merck strengthens Gonal-f portfolio with approval for 150 IU pen in the European Union
22 January 2020 - New Gonal-f 150 IU pen provides additional flexibility and convenience at every stage of the patients’ stimulation ...
Posted by Michael Wonder on 22 Jan 2020
NHS patients denied new lung cancer drug after another NICE deadlock
22 January 2020 - Certain untreated lung cancer patients on England’s NHS will have to make do with older drugs ...
Posted by Michael Wonder on 22 Jan 2020
EU group calls for 'targeted actions' to mitigate impact of Brexit
22 January 2020 - Committee wants to ensure safe supply of drugs and medical devices. ...
Posted by Michael Wonder on 22 Jan 2020
FDA accepts Evoke Pharma’s NDA resubmission for Gimoti
21 January 2020 - PDUFA Target Goal Date is 19 June 2020. ...
Posted by Michael Wonder on 22 Jan 2020
NICE rejects Janssen’s Stelara on cost efficiency grounds
22 January 2020 - NICE has released a draft guidance not recommending Janssen’s Stelara (ustekinumab) for moderately to severely active ...